Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 144,800 Reduced 0.69% |
$33,304
$0.23 p/Share
|
Jan 18
2021 |
ORRF
|
Barbara E Brobst
Director |
SELL
Open market or private sale
|
Direct | 3,596 Reduced 21.4% |
$64,800
$18.02 p/Share
|
Jan 18
2021 |
ORRF
|
David Todd Hornberger
EVP, Market President |
SELL
Open market or private sale
|
Direct | 2,433 Reduced 11.22% |
$43,843
$18.02 p/Share
|
Jan 18
2021 |
ORRF
|
Adam L Metz
SEVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 5,284 Reduced 31.23% |
$95,218
$18.02 p/Share
|
Jan 18
2021 |
ORRF
|
Jeffrey S Gayman
EVP, Mortgage & Retail |
SELL
Open market or private sale
|
Direct | 4,516 Reduced 29.49% |
$81,378
$18.02 p/Share
|
Jan 18
2021 |
ORRF
|
Philip E Fague
EVP, Trust & Wealth |
SELL
Open market or private sale
|
Direct | 1,978 Reduced 4.97% |
$35,644
$18.02 p/Share
|
Jan 18
2021 |
TRT
|
Hock Ming Ting |
SELL
Open market or private sale
|
Direct | 12,594 Reduced 11.9% |
$56,169
$4.46 p/Share
|
Jan 16
2021 |
EW
|
Michael A Mussallem
Director |
SELL
Open market or private sale
|
Direct | 68,550 Reduced 24.5% |
$6,011,835
$87.7 p/Share
|
Jan 15
2021 |
STX
|
Value Act Holdings, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 8,706 Reduced 0.03% |
$522,795
$60.05 p/Share
|
Jan 15
2021 |
NET
|
Michelle Zatlyn
President and Board Co-Chair |
SELL
Open market or private sale
|
Indirect | 48,700 Reduced 76.06% |
$3,890,156
$79.88 p/Share
|
Jan 15
2021 |
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 5.69% |
$167,930
$47.98 p/Share
|
Jan 15
2021 |
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.67% |
$246,300
$8.21 p/Share
|
Jan 15
2021 |
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.67% |
$246,300
$8.21 p/Share
|
Jan 15
2021 |
BCYC
|
Kevin Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.85% |
$135,050
$27.01 p/Share
|
Jan 15
2021 |
SURF
|
Robert W. Ross
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 2.2% |
$24,500
$12.25 p/Share
|
Jan 15
2021 |
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 211,204 Reduced 18.24% |
$16,518,265
$78.21 p/Share
|
Jan 15
2021 |
DIS
|
Christine M Mc Carthy
SEVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,139 Reduced 2.64% |
$716,047
$173.0 p/Share
|
Jan 15
2021 |
EW
|
Huimin Wang
CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct | 11,730 Reduced 11.17% |
$1,023,677
$87.27 p/Share
|
Jan 15
2021 |
EW
|
Catherine M. Szyman
CVP, Critical Care |
SELL
Open market or private sale
|
Direct | 3,389 Reduced 11.25% |
$295,758
$87.27 p/Share
|
Jan 15
2021 |
SGEN
|
Jean I Liu
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 7.66% |
$900,000
$180.0 p/Share
|
Jan 15
2021 |
LW
|
Thomas P. Werner
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 69,500 Reduced 18.16% |
$5,396,675
$77.65 p/Share
|
Jan 15
2021 |
PENN
|
Christine La Bombard
SVP and CAO |
SELL
Open market or private sale
|
Direct | 11,831 Reduced 48.99% |
$1,236,458
$104.51 p/Share
|
Jan 15
2021 |
KTOS
|
Phillip D Carrai
President, STC Division |
SELL
Open market or private sale
|
Direct | 1,363 Reduced 1.4% |
$41,176
$30.21 p/Share
|
Jan 15
2021 |
CSWI
|
Joseph B Armes
Chairman, President & CEO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 4.41% |
$247,700
$123.85 p/Share
|
Jan 15
2021 |
WRLD
|
Darrell E Whitaker
Director |
SELL
Open market or private sale
|
Direct | 660 Reduced 7.01% |
$94,281
$142.85 p/Share
|
Jan 15
2021 |
WRLD
|
Luke J. Umstetter
Officer |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.79% |
$28,570
$142.85 p/Share
|
Jan 15
2021 |
NX
|
Scott M. Zuehlke
Senior VP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 8,300 Reduced 24.05% |
$210,073
$25.31 p/Share
|
Jan 15
2021 |
WETF
|
Amit Muni
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 10.08% |
$399,750
$5.33 p/Share
|
Jan 15
2021 |
SWBI
|
Robert L Scott |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 3.13% |
$63,780
$21.26 p/Share
|
Jan 15
2021 |
JOUT
|
David W Johnson
Vice President and CFO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 5.16% |
$112,730
$112.73 p/Share
|
Jan 15
2021 |
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.46% |
$21,050
$21.05 p/Share
|
Jan 15
2021 |
INO
|
Peter Kies
CFO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 20.1% |
$300,600
$10.02 p/Share
|
Jan 15
2021 |
ASXC
|
David Bruce Milne
Director |
SELL
Open market or private sale
|
Direct | 147,058 Reduced 41.5% |
$308,822
$2.1 p/Share
|
Jan 15
2021 |
WLY
|
Christopher Caridi
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,126 Reduced 100.0% |
$53,339
$47.37 p/Share
|
Jan 15
2021 |
REPL
|
Colin Love
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 22,143 Reduced 2.27% |
$973,406
$43.96 p/Share
|
Jan 15
2021 |
MAS
|
John G Sznewajs
VP and CFO |
SELL
Open market or private sale
|
Direct | 10,692 Reduced 4.85% |
$597,255
$55.86 p/Share
|
Jan 15
2021 |
MAS
|
Keith J. Allman
President and CEO |
SELL
Open market or private sale
|
Direct | 32,586 Reduced 10.09% |
$1,820,254
$55.86 p/Share
|
Jan 15
2021 |
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 26,677 Reduced 0.68% |
$690,934
$25.9 p/Share
|
Jan 15
2021 |
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 0.48% |
$546,900
$18.23 p/Share
|
Jan 15
2021 |
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 14,400 Reduced 0.16% |
$984,816
$68.39 p/Share
|
Jan 15
2021 |
BGNE
|
Howard Liang
CFO & Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 12,600 Reduced 100.0% |
$4,346,496
$344.96 p/Share
|
Jan 15
2021 |
VLY
|
Kevin J Lynch
Director |
SELL
Open market or private sale
|
Direct | 300,000 Reduced 80.13% |
$3,198,000
$10.66 p/Share
|
Jan 15
2021 |
CVET
|
Anthony C. Providenti Jr.
Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 29.58% |
$183,950
$36.79 p/Share
|
Jan 15
2021 |
CVET
|
Dustin Finer
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 2,630 Reduced 8.77% |
$96,547
$36.71 p/Share
|
Jan 15
2021 |
ALLO
|
Eric Thomas Schmidt
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 0.43% |
$486,900
$32.46 p/Share
|
Jan 15
2021 |
CODI
|
Anholt Investments Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 980 Reduced 0.01% |
$20,737
$21.16 p/Share
|
Jan 15
2021 |
REPL
|
Philip Astley Sparke
Director |
SELL
Open market or private sale
|
Direct | 16,568 Reduced 1.29% |
$727,170
$43.89 p/Share
|
Jan 15
2021 |
REPL
|
Pamela Esposito
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 29,273 Reduced 14.26% |
$1,275,717
$43.58 p/Share
|
Jan 15
2021 |
REPL
|
Omega Fund Iv, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,916 Reduced 0.04% |
$86,584
$45.19 p/Share
|
Jan 15
2021 |
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 14,289 Reduced 0.5% |
$435,672
$30.49 p/Share
|
Jan 15
2021 |